Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_assertion type Assertion NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_head.
- NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_assertion description "[Key members of the vascular endothelial growth factor (VEGF) and angiopoietin families of vascular growth factors (and their corresponding tyrosine kinase endothelial receptors) have been identified which preferentially influence lymphatic growth and, when manipulated in genetically engineered murine models, produce aberrant 'lymphatic phenotypes.' Moreover, mutations in VEGF receptor and forkhead family developmental genes have now been linked and implicated in the pathogenesis of two familial lymphedema-angiodysplasia syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_provenance.
- NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_assertion evidence source_evidence_literature NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_provenance.
- NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_assertion SIO_000772 11596157 NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_provenance.
- NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_assertion wasDerivedFrom befree-20150227 NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_provenance.
- NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_assertion wasGeneratedBy ECO_0000203 NP771259.RA4qh4Ot88M8rO234E_U83_UXVrM6Jw60RSfl7m1E3pkU130_provenance.